Is obesity-induced ECM remodeling a prelude to the development of various diseases?

被引:2
|
作者
Rahimi, Azam [1 ]
Rasouli, Mehdi [1 ]
Keshel, Saeed Heidari [1 ]
Ebrahimi, Maryam [2 ]
Pakdel, Farzad [3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Tissue Engn & Appl Cell Sci, Tehran, Iran
[2] Farabi Eye Hosp, Dept Ophthalm Plast & Reconstruct Surg, Tehran, Iran
[3] Univ Tehran Med Sci, Eye Res Ctr, Ophthalmol Dept, Tehran, Iran
关键词
Extracellular matrix; Remodeling; Insulin resistance; Obesity; Organ crosstalk; Organ dysfunction; HIGH-FAT DIET; ADIPOSE-TISSUE; EXTRACELLULAR-MATRIX; SKELETAL-MUSCLE; EXPRESSION; ACTIVATION; INCREASES; LOCALIZATION; INFLAMMATION; ANGIOGENESIS;
D O I
10.1016/j.orcp.2023.02.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Due to the increasing incidence rate of obesity worldwide and the associated complications such as type 2 diabetes and cardiovascular diseases, research on the adipose tissue physiology and the role of the extracellular matrix (ECM) has gained tremendous attention. The ECM, one of the most crucial components in body tissues, undergoes remodeling and regeneration of its constituents to guarantee normal tissue function. There is a crosstalk between fat tissue and various body organs, including but not limited to the liver, heart, kidney, skeletal muscle, and so forth. These organs respond to fat tissue signals through changes in ECM, function, and their secretory products. Obesity can cause ECM remodeling, inflammation, fibrosis, insulin resistance, and disrupted metabolism in different organs. However, the mechanisms underlying the reciprocal communication between various organs during obesity are still not fully elucidated. Gaining a profound knowledge of ECM alterations during the progression of obesity will pave the way toward developing potential strategies to either circumvent pathological conditions or open an avenue to treat complications associated with obesity.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 50 条
  • [21] Mechanisms of obesity-induced hypertension
    Hall, JE
    Zappe, DH
    AlonsoGalicia, M
    Granger, JP
    Brands, MW
    Kassab, SE
    NEWS IN PHYSIOLOGICAL SCIENCES, 1996, 11 : 255 - 261
  • [22] Management of obesity-induced arthritis
    Lohmander, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 5 - 6
  • [23] URINARY METABOLITE BIOMARKERS CHANGES IN OBESITY-INDUCED NAFLD AND OBESITY-INDUCED NAFLD PLUS XX
    Yong, Helena
    Chan, Ka Lung Andrew
    Larrouy-Maumus, Gerald
    Okor, Joseph
    Munday, Michael
    Hall, Andrew
    Quaglia, Alberto
    Oben, Jude
    GUT, 2023, 72 : A41 - A41
  • [24] Mechanisms of obesity-induced hypertension
    Montani, J. P.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S9 - S9
  • [25] Pregestational Obesity-Induced Embryopathy
    Gipsis Suárez-Román
    Tammy Fernández-Romero
    Alfredo J. Perera-Calderín
    Víctor M. Rodríguez-Sosa
    Celeste Arranz
    Sonia Clapes Hernandez
    Reproductive Sciences, 2016, 23 : 1250 - 1257
  • [26] Mechanisms of obesity-induced hypertension
    Kotsis, Vasilios
    Stabouli, Stella
    Papakatsika, Sofia
    Rizos, Zoe
    Parati, Gianfranco
    HYPERTENSION RESEARCH, 2010, 33 (05) : 386 - 393
  • [27] Obesity-induced neutrophil reprogramming
    Gummlich, Linda
    NATURE REVIEWS CANCER, 2021, 21 (07) : 412 - 412
  • [28] Obesity-Associated ECM Remodeling in Cancer Progression
    Li, Junyan
    Xu, Ren
    CANCERS, 2022, 14 (22)
  • [29] URINARY METABOLITE BIOMARKERS CHANGES IN OBESITY-INDUCED NAFLD AND OBESITY-INDUCED NAFLD PLUS XX
    Yong, Helena
    Chan, Ka Lung Andrew
    Larrouy-Maumus, Gerald
    Okor, Joseph
    Munday, Michael
    Hall, Andrew
    Quaglia, Alberto
    Oben, Jude
    GUT, 2023, 72 (SUPPL_3) : A41 - A41
  • [30] Identification of key immune regulators that control obesity-induced liver inflammation and diseases
    Zhong, Zhenyu
    Umemura, Atsushi
    Liang, Shuang
    Karin, Michael
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)